Selective laser trabeculoplasty in exfoliative glaucoma eyes with prior argon laser trabeculoplasty.
ALT
exfoliative glaucoma
intraocular pressure
pseudoexfoliation syndrome
selective laser trabeculoplasty
Journal
Acta ophthalmologica
ISSN: 1755-3768
Titre abrégé: Acta Ophthalmol
Pays: England
ID NLM: 101468102
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
23
09
2018
accepted:
15
04
2019
pubmed:
16
5
2019
medline:
20
11
2020
entrez:
16
5
2019
Statut:
ppublish
Résumé
To explore the efficacy of selective laser trabeculoplasty (SLT) within eyes with exfoliative glaucoma and history of prior argon laser trabeculoplasty (ALT). A single-centre trial consisting of 47 patients (47 eyes) with uncontrolled exfoliative glaucoma. The main outcome measure was intraocular pressure (IOP) reduction 3 and 9 months after SLT. Treatment success was defined as reduction from the preoperative IOP by 20% and 2 mmHg (<12 mmHg), 3 mmHg (12-16 mmHg) or 4 mmHg (>16 mmHg) depending on the baseline IOP. Patient age was 79.3 ± 7.6 years (mean ± SD) and gender distribution 15 males and 32 females. The mean pre-SLT IOP was 15.6 ± 5.1 (range 9-28) mmHg, and mean number of glaucoma drugs 2.0 ± 1.2. The mean interval between prior ALT and SLT was 44.0 ± 36.9 (range 11-137) months. After SLT, the mean IOP change was -2.7 ± 4.2 mmHg (-14.8 ± 23.5%) at 3 months, and -2.8 ± 3.5 mmHg (-16.3 ± 19.4%) at 9 months. Pre-SLT IOP correlated with the IOP reduction at 3 months (r = 0.530, p < 0.001) and at 9 months (r = 0.432, p = 0.007). The overall success rate was 50% at 3 months, and 42% at 9 months. At both 3 and at 9 months, the cut-off level for treatment success was achieved when preoperative IOP was 18 mmHg and above. IOP lowering effect of SLT did not correlate with the number of glaucoma drugs, age, gender or use of prostaglandin inhibitors. Neither postoperative iritis nor other adverse effects were documented during the follow-up. Selective laser trabeculoplasty is a safe and noteworthy treatment option to reduce IOP in exfoliative glaucoma eyes, especially with pre-SLT IOP over 18 mmHg.
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
58-64Subventions
Organisme : Paulon Säätiö
Organisme : Orionin Tutkimussäätiö
Organisme : Waldemar von Frenckell Foundation
Organisme : Finnish Ophthalmological Society
Organisme : HUS Specific Catchment Area (ERVA) Clinical Research Grants
Organisme : Nissi foundation
Organisme : Finnish Eye foundation
Organisme : Glaukooma tukisäätiö LUX
Informations de copyright
© 2019 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
Références
Abdelrahman AM (2015): Noninvasive glaucoma procedures: current options and future innovations. Middle East Afr J Ophthalmol 22: 2-9.
Astrom S, Stenlund H & Linden C (2007): Incidence and prevalence of pseudoexfoliations and open-angle glaucoma in northern Sweden: II. Results after 21 years of follow-up. Acta Ophthalmol Scand 85: 832-837.
Ayala M & Chen E (2011): Predictive factors of success in selective laser trabeculoplasty (SLT) treatment. Clini Ophthalmol 5: 573-576.
Barkana Y & Belkin M (2007): Selective laser trabeculoplasty. Surv Ophthalmol 52: 634-654.
Barnebey HS & Robin AL (2016): Adherence to fixed-combination versus unfixed travoprost 0.004%/timolol 0.5% for glaucoma or ocular hypertension: a randomized trial. Am J Ophthalmol 176: 61-69.
Bergeå B (1984): Some factors affecting the intraocular pressure reduction after argon laser trabeculoplasty in open-angle glaucoma. Acta Ophthalmol 62: 696-704.
Birt CM (2007): Selective laser trabeculoplasty retreatment after prior argon laser trabeculoplasty: 1-year results. Can J Ophthalmol. Journal canadien d'ophtalmologie. 42: 715-719.
Blika S & Saunte E (1982): Timolol maleate in the treatment of glaucoma simplex and glaucoma capsulare a three-year follow up study. Acta Ophthalmol 60: 967-976.
Bruen R, Lesk MR & Harasymowycz P (2012): Baseline Factors Predictive of SLT Response: a Prospective Study. J Ophthalmol 2012: 642869.
Chiselita D, Cantemir A & Pantalon AD (2015): Selective laser trabeculoplasty--short term efficacy and safety profile in open angle glaucoma or ocular hypertension treatment. Rom J Ophthalmol 59: 148-153.
Damji KF, Shah KC, Rock WJ, Bains HS & Hodge WG (1999): Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial. Br J Ophthalmol 83: 718-722.
De Keyser M, De Belder M, De Belder S & De Groot V (2016): Where does selective laser trabeculoplasty stand now? A review Eye Vis (London, England) 3: 10-10.
Desai MA & Lee RK (2008): The medical and surgical management of pseudoexfoliation glaucoma. Int Ophthalmol Clin 48: 95-113.
Francis BA, Loewen N, Hong B et al. (2016): Repeatability of selective laser trabeculoplasty for open-angle glaucoma. BMC Ophthalmol 16: 128.
Futa R, Shimizu T, Furuyoshi N, Nishiyama M & Hagihara O (1992): Clinical features of capsular glaucoma in comparison with primary open-angle glaucoma in Japan. Acta Ophthalmol 70: 214-219.
Gracner T (2002): Intraocular pressure response of capsular glaucoma and primary open-angle glaucoma to selective Nd:YAG laser trabeculoplasty: a prospective, comparative clinical trial. Eur J Ophthalmol 12: 287-292.
Heijl A, Peters D, Leske MC & Bengtsson B (2011): Effects of argon laser trabeculoplasty in the early manifest glaucoma trial. Am J Ophthalmol 152: 842-848.
Higginbotham EJ & Richardson TM (1986): Response of exfoliation glaucoma to laser trabeculoplasty. Br J Ophthalmol 70: 837-839.
Hirn C, Zehnder S, Bauer G, Jaggi GP, Toteberg-Harms M, Zweifel SA, Lindegger DJ & Funk J (2014): Long-term efficacy of selective laser trabeculoplasty in patients on prostaglandin therapy. Klin Monatsbl Augenheilkd 231: 351-356.
Hirvela H, Tuulonen A & Laatikainen L (1994): Intraocular pressure and prevalence of glaucoma in elderly people in Finland: a population-based study. Int Ophthalmol 18: 299-307.
Hodge WG, Damji KF, Rock W, Buhrmann R, Bovell AM & Pan Y (2005): Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial. Br J Ophthalmol 89: 1157-1160.
Ilveskoski L & Tuuminen R (2017): Combined microinvasive glaucoma and cataract surgery in patients with pseudoexfoliation glaucoma: clinical results of a gel stent. J Cataract Refract Surg 43: 1124-1125.
Juzych MS, Chopra V, Banitt MR, Hughes BA, Kim C, Goulas MT & Shin DH (2004): Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology 111: 1853-1859.
Kara N, Altan C, Yuksel K & Tetikoglu M (2013): Comparison of the efficacy and safety of selective laser trabeculoplasty in cases with primary open-angle glaucoma and pseudoexfoliative glaucoma. Kaohsiung J Med Sci 29: 500-504.
Katsanos A, Konstas AG, Mikropoulos DG, Quaranta L, Voudouragkaki IC, Athanasopoulos GP, Asproudis I & Teus MA (2018): A review of the clinical usefulness of selective laser trabeculoplasty in exfoliative glaucoma. Adv Ther 35: 619-630.
Kent SS, Hutnik CM, Birt CM et al. (2015): A randomized clinical trial of selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with pseudoexfoliation. J Glaucoma 24: 344-347.
Kramer TR & Noecker RJ (2001): Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology 108: 773-779.
Krause U, Alanko HI, Karna J, Miettinen R, Larmi T, Jaanio E, Ollila OI & Takala J (1988): Prevalence of exfoliation syndrome in Finland. Acta Ophthalmol 66(Supplement 184): 120-122.
Latina MA, Sibayan SA, Shin DH, Noecker RJ & Marcellino G (1998): Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology 105: 2082-2090.
Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L & Yang Z (2007): Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114: 1965-1972.
Mao AJ, Pan XJ, McIlraith I et al. (2008): Development of a prediction rule to estimate the probability of acceptable intraocular pressure reduction after selective laser trabeculoplasty in open-angle glaucoma and ocular hypertension. J Glaucoma 17: 449-454.
Martow E, Hutnik CM & Mao A (2011): SLT and adjunctive medical therapy: a prediction rule analysis. J Glaucoma 20: 266-270.
McIlraith I, Strasfeld M, Colev G & Hutnik CM (2006): Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma 15: 124-130.
Melamed S, Ben Simon GJ & Levkovitch-Verbin H (2003): Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, nonrandomized pilot study. Arch Ophthalmol 121: 957-960.
Miraftabi A, Nilforushan N, Nassiri N & Nouri-Mahdavi K (2016): Selective laser trabeculoplasty in patients with pseudoexfoliative glaucoma vs primary open angle glaucoma: a one-year comparative study. Int J Ophthalmol 9: 406-410.
Pham H, Mansberger S & Brandt JD (2008): I. Argon laser trabeculoplasty. The gold standard. Surv Ophthalmol 53: 641-646.
Plateroti P, Plateroti AM, Abdolrahimzadeh S & Scuderi G (2015): Pseudoexfoliation syndrome and pseudoexfoliation glaucoma: a review of the literature with updates on surgical management. J Ophthalmol 2015: 370371.
Scherer WJ (2007): Effect of topical prostaglandin analog use on outcome following selective laser trabeculoplasty. J Ocul Pharmacol Ther 23: 503-512.
Sharpe RA, Kammerdiener LL, Williams DB, Das SK & Nutaitis MJ (2018): Efficacy of selective laser trabeculoplasty following incisional glaucoma surgery. Int J Ophthalmol 11: 71-76.
Song J, Lee PP, Epstein DL, Stinnett SS, Herndon LW Jr, Asrani SG, Allingham RR & Challa P (2005): High failure rate associated with 180° selective laser trabeculoplasty. J Glaucoma 14: 400-408.
Song JSA, Vianna J, Shuba L, Rafuse P & Nicolela M (2018): Evaluating selective laser trabeculoplasty versus argon laser trabeculoplasty in pseudoexfoliation glaucoma patients. Can J Ophthalmol 53: 70-75.
Tarkkanen AHA & Kivelä TT (2014): Comparison of primary open-angle glaucoma and exfoliation glaucoma at diagnosis. Eur J Ophthalmol 25: 137-139.
Threlkeld AB, Hertzmark E, Sturm RT, Epstein DL & Allingham RR (1996): Comparative study of the efficacy of argon laser trabeculoplasty for exfoliation and primary open-angle glaucoma. J Glaucoma 5: 311-316.
Tuulonen A, Airaksinen PJ & Kuulasmaa K (1985): Factors influencing the outcome of laser trabeculoplasty. Am J Ophthalmol 99: 388-391.
Tuulonen A, Forssan E, Hagman J et al. (2015): Update on current care guideline: glaucoma. Duodecim 131: 356-358.
Vandenbroeck S, De Geest S, Dobbels F, Fieuws S, Stalmans I & Zeyen T (2011): Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO). J Glaucoma 20: 414-421.
Vesti E & Kivelä T (2000): Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res 19: 345-368.
Zhou Y & Aref AA (2017): A review of selective laser trabeculoplasty: recent findings and current perspectives. Ophthalmol Ther 6: 19-32.